Sinsin Pharmaceutical Co., Ltd (KOSDAQ:002800)
5,840.00
-40.00 (-0.68%)
At close: Apr 20, 2026
Sinsin Pharmaceutical Revenue
In the year 2025, Sinsin Pharmaceutical had annual revenue of 113.78B KRW with 6.95% growth. Sinsin Pharmaceutical had revenue of 28.76B in the quarter ending December 31, 2025, with 13.83% growth.
Revenue
113.78B
Revenue Growth
+6.95%
P/S Ratio
0.78
Revenue / Employee
319.60M
Employees
356
Market Cap
88.60B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 113.78B | 7.39B | 6.95% |
| Dec 31, 2024 | 106.39B | 3.80B | 3.71% |
| Dec 31, 2023 | 102.59B | 10.66B | 11.60% |
| Dec 31, 2022 | 91.93B | 17.92B | 24.21% |
| Dec 31, 2021 | 74.01B | 6.88B | 10.25% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Ahn-Gook Pharmaceutical | 306.87B |
| Cosmax Nbt | 287.48B |
| H.PIO | 258.19B |
| Daehan Nupharm | 202.40B |
| Hwail Pharmaceutical | 107.87B |
| Sinil Pharmaceutical | 80.56B |
| Sam-A Pharm. | 77.80B |
| Polaris AI Pharma | 63.94B |